San Luis Obispo, CA1 Active Studies

Pulmonary Hypertension Clinical Trials in San Luis Obispo, CA

Find 1 actively recruiting pulmonary hypertension clinical trials in San Luis Obispo, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
320
Enrolling

Recruiting Pulmonary Hypertension Studies in San Luis Obispo

About Pulmonary Hypertension Clinical Trials in San Luis Obispo

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 1 pulmonary hypertension clinical trials recruiting participants in San Luis Obispo, CA. These studies are seeking a combined 320 participants. Research is being sponsored by Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in San Luis Obispo — FAQ

Are there pulmonary hypertension clinical trials in San Luis Obispo?

Yes, there are 1 pulmonary hypertension clinical trials currently recruiting in San Luis Obispo, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Luis Obispo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Luis Obispo research site will contact you about next steps.

Are clinical trials in San Luis Obispo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Luis Obispo studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 1 active trials in San Luis Obispo are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 22, 2026 from ClinicalTrials.gov